Long‐Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five‐Year Observational Study

Autor: Kevin L. Winthrop, Kenneth Saag, Matthew D. Cascino, Jinglan Pei, Ani John, Angelika Jahreis, Tmirah Haselkorn, Daniel E. Furst, M. Abdulky, M. Abeles, H. Adelglass, A. Ahmed, J. Alloway, J. Alper, A. Anand, J. Anderson, M. Arora, A. Askari, S. Baca, D. Bacha, S. Bagheri, S. Ballou, R. Bennett, L. Bidula, H. Blumstein, M. Bognar, A. Bohan, C. Boniske, M. Borofsky, E. Box, A. Braun, T. Brennan, L. Brent, I. Cabalar, N. Carteron, K. Chaudhary, A. Chauhan, M. Cima, A. Cochinwala, H. Cohen, K. Colburn, D. Conaway, C. Danning, K. Dao, J. Dean, I. Diab, R. Diegel, R. Ditzian‐Kadanoff, J. Dowd, C. Dugowson, A. Eggebeen, H. El‐Kadi, H. Feinberg, M. Feinman, J. Feinstein, A. Fischer, B. Foad, M. Fondal, S. Fraser, A. Fraser, P. Freeman, M. Garber, A. Goldstein, S. Golombek, N. Greenstein, M. Greenwald, C. Hakim, J. Halla, D. Hallegua, K. Han, B. Harris, H. Hauptman, J. Hirsh, M. Hoffman, J. Huntwork, M. Husni, F. Hyer, R. Hymowitz, R. Jones, S. Kanagasegar, J. Kappes, R. Keating, G. Kelly, J. Kim, C. King, D. Klashman, C. Knee, K. Kolba, G. Krick, H. Krug, U. Kumar, S. Lakhanpal, T. Lang, S. Lauter, T. Lawrence Ford, W. Lee, Y. Lee, J. Leisen, J. Levine, R. Lidman, J. Lipstate, J. Malinak, R. Marcus, D. Martin, C. Mehta, G. Melton, S. Metyas, K. Miller, R. Moidel, C. Moore, J. Mossell, G. Munoz, F. Murphy, A. Nami, J. Nascimento, N. Neal, R. Neiman, C. Neuwelt, P. Nguyen, M. Niemer, K. Oelke, M. Oza, S. Pachaidee, S. Patel, S. Pegram, M. Penmetcha, J. Perkins, A. Perl, L. Peterson, R. Pittsley, K. Portnoff, D. Rahmani, N. Raja, W. Ratnoff, M. Rezaian, C. Rhea, D. Rice, D. Ridley, A. Rivadeneira, W. Rizzo, G. Roane, P. Rocca, M. Rosen, W. Saikali, M. Saitta, A. Sankoorikal, P. Saway, P. Schneider, S. Schwartzman, C. Scoville, W. Shergy, W Shiel, R. Shurmur, D. Sikes, A. Singhal, A. Snyder, S. Songcharoen, M. Sosenko, O. Soto Raices, N. Stahl, K. Stark, M. Strachan, A. Stupi, N. Sullivan, R. Sylvester, D. Tabechian, C. Tagoe, P. Taylor, S. Thakker, M. Thakor, N. Thakur, W. Tidmore, M. Toth, D. Trostle, J. Udell, M. Van de Stouwe, R. Venuturupalli, D. Weiss, K. Weselman, D. Winn, C. Yung, E. Zable, B. Zamiri

Publikováno v: Arthritis Care & Research

Objective To evaluate the long‐term safety of rituximab in an observational cohort of patients with rheumatoid arthritis (RA) who had an inadequate response to ≥1 anti–tumor necrosis factor therapy in the US (SUNSTONE [Study of the Safety of Ri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5502e0d966222c7403f4d23428329950
https://doi.org/10.1002/acr.23781

Multicentric reticulohistiocytosis: Case report with immunohistochemical analysis and literature review

Autor: Schumacher Hr, John H. Klippel, John C. Davis, Jennifer D. Gorman, C Danning

Publikováno v: Arthritis & Rheumatism. 43:930

This report describes the case of a patient with multicentric reticulohistiocytosis. Immunohistochemical analysis revealed prominent markers of monocyte/macrophage origin, as well as the presence of tumor necrosis factor alpha, interleukin-1beta (IL-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::576cbbc8dce9f83efcc58cecdeae3d26
https://doi.org/10.1002/1529-0131(200004)43:4<930::aid-anr27>3.0.co

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.